Navigation Links
Einstein study indicates brain plays role in regulating blood sugar in humans
Date:11/7/2011

November 7, 2011 (Bronx, NY) Researchers at Albert Einstein College of Medicine of Yeshiva University have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans. The findings, published today in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes.

"The brain is the body's only organ that needs a constant supply of glucose to survive, so it makes sense that it would have some say over how much glucose is produced," said study leader Meredith Hawkins, M.D., professor of medicine and director of the Global Diabetes Initiative at Einstein. "This role for the brain was demonstrated in earlier Einstein studies in rodents, but there was considerable controversy over whether the results could be applied to humans. We hope this study helps to settle the matter."

In an earlier study in rodents, Einstein researchers showed that activation of potassium channels in the brain's hypothalamus sends signals to the liver that dampen its production of glucose. Those findings, published in Nature in 2005, challenged the conventional thinking that blood sugar production by the liver (the body's glucose factory) is regulated only by the pancreas (which makes insulin to metabolize glucose). But carefully performed studies on dogs, conducted at Vanderbilt University, failed to replicate the results, suggesting the Einstein findings in rodents might not be relevant to higher mammals, including humans.

The current Einstein study, involving people, was aimed at resolving this controversy. Ten nondiabetic subjects were given oral diazoxide, a drug that activates potassium channels in the hypothalamus. (The drug is not used to treat diabetes.) Hormone secretion by the pancreas was controlled to ensure that any change in sugar production would only have occurred through the drug's effect on the brain. After the researchers administered the drug, blood tests revealed that patients' livers were producing significantly less glucose than before.

Dr. Hawkins and her team then repeated this in rats, again giving diazoxide orally, achieving similar results. They confirmed that sufficient amounts of diazoxide crossed the blood-brain barrier to affect potassium channels in the hypothalamus. Additional experiments confirmed that diazoxide was working through the brain. Specifically, the researchers were able to completely block the effects of diazoxide by infusing a specific potassium channel blocker directly into the brain.

"This study confirms that the brain plays a significant role in regulating glucose production by the liver," said lead author Preeti Kishore, M.B.B.S., assistant professor of medicine. "We are now investigating whether this 'brain-to-liver' pathway is impaired in people with diabetes. If so, we may be able to restore normal glucose regulation by targeting potassium channels in the brain."


'/>"/>

Contact: Kim Newman
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Albert Einstein College of Medicine receives $8 million from NIH to study how cancer spreads
2. Einstein College of Medicine given $6.7 million to study congenital heart defect genetics
3. Einstein offers easy-to-use genome analyzer to scientific community
4. Einstein researchers find key gene in childhood cancer
5. Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship
6. Einstein researcher receives American Cancer Society Medal of Honor
7. Einstein receives $30 million to study protein form and function
8. Einstein designated an NIH Center of Excellence for aging research
9. Einstein receives $4 million to test HPV microbicide
10. Einstein researcher awarded prestigious cancer research grant
11. Einstein-Montefiore research tackles childhood obesity in the Bronx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical ... 12.14 billion by 2021 from USD 5.31 billion in 2016, at ... ... mainly driven by technological advancements in medical devices, launch of a ... preference for wireless connectivity among healthcare providers, and increasing focus on ...
(Date:12/15/2016)... Mich. , Dec. 15, 2016  There is ... car doors or starting the engine. Continental will demonstrate ... Las Vegas . Through the combination ... Start and Entry) and biometric elements, the international technology ... of vehicle personalization and authentication. "The integration ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... international society for optics and photonics , are commending the U.S. Congress and ... the signing Friday by the President of the American Innovation and Competitiveness Act ...
(Date:1/11/2017)... Ca (PRWEB) , ... January 11, 2017 , ... ... in pathogens are observed in clinical settings, it is becoming increasingly clear that ... An over-reliance on culture-based methods, the standard in the study of clinical resistance, ...
(Date:1/11/2017)... PA (PRWEB) , ... January 11, 2017 , ... ... entrepreneur can make all the difference when navigating the challenges young businesses face. ... tap into the extensive expertise and experience of Geoff DiMasi, Founder and Principal ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced Polymer Monitoring Technologies (APMT) ... Bartylla will lead European initiatives for APMT’s product lines serving polymer and biopharmaceutical ... to European manufacturers and researchers. Bernhard brings significant experience in our application areas ...
Breaking Biology Technology: